81 related articles for article (PubMed ID: 18446822)
41. Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties.
Takahashi H; Fujita K; Fujisawa T; Yonemitsu K; Tomimoto A; Ikeda I; Yoneda M; Masuda T; Schaefer K; Saubermann LJ; Shimamura T; Saitoh S; Tachibana M; Wada K; Nakagama H; Nakajima A
Cancer Sci; 2006 Sep; 97(9):854-60. PubMed ID: 16805824
[TBL] [Abstract][Full Text] [Related]
42. Hungry for blood vessels: linking metabolism and angiogenesis.
Fraisl P; Baes M; Carmeliet P
Dev Cell; 2008 Mar; 14(3):313-4. PubMed ID: 18331707
[TBL] [Abstract][Full Text] [Related]
43. Treating gliomas with glucocorticoids: from bedside to bench.
Piette C; Munaut C; Foidart JM; Deprez M
Acta Neuropathol; 2006 Dec; 112(6):651-64. PubMed ID: 16855833
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of morphological issues of central nervous system glioblastoma on chicken embryo chorioallantoic membrane.
Tereseviciūte N; Tamasauskas A; Valanciūte A; Deltuva V; von graf KD
Pol J Vet Sci; 2007; 10(3):173-8. PubMed ID: 17937190
[TBL] [Abstract][Full Text] [Related]
45. Biological Rationale for the Use of PPARγ Agonists in Glioblastoma.
Ellis HP; Kurian KM
Front Oncol; 2014; 4():52. PubMed ID: 24672773
[TBL] [Abstract][Full Text] [Related]
46. [Studies of endoneoplastic transformation of gliomas in long-term cultures and subcultures in vitro].
Kaluza J; Kowalska Z
Neuropatol Pol; 1972; 10(3):435-45. PubMed ID: 4342749
[No Abstract] [Full Text] [Related]
47. Ex vivo enrichment of malignant carcinoma cells in primary culture.
Heinzman JM; Brower SL; Bush JE; Silverman JF
Pathology; 2007 Oct; 39(5):491-4. PubMed ID: 17886099
[TBL] [Abstract][Full Text] [Related]
48. A method of studying metabolic variation between individual tumors: a preliminary report.
Rogers S; Robertson JT
Nutr Cancer; 1981; 2(3):148-9. PubMed ID: 6287435
[No Abstract] [Full Text] [Related]
49. [Behavior of gliomas in tissue cultures. I. The astrocytoma-glioblastoma group].
PALYI I; AFRA D; CSANDA E
Ideggyogy Sz; 1961 Aug; 14():225-37. PubMed ID: 13732366
[No Abstract] [Full Text] [Related]
50. Analysis of enzymatic activities of clones derived from variant cell lines transformed to malignant cells in tissue culture.
SCOTT DB; PAKOSKEY AM; SANFORD KK
J Natl Cancer Inst; 1960 Dec; 25():1365-79. PubMed ID: 13749340
[No Abstract] [Full Text] [Related]
51. Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?
Nunez CV; de Vasconcellos MC; Alaniz L
Front Pharmacol; 2022; 13():1055516. PubMed ID: 36339558
[No Abstract] [Full Text] [Related]
52. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
Jiang Y; Marinescu VD; Xie Y; Jarvius M; Maturi NP; Haglund C; Olofsson S; Lindberg N; Olofsson T; Leijonmarck C; Hesselager G; Alafuzoff I; Fryknäs M; Larsson R; Nelander S; Uhrbom L
Cell Rep; 2017 May; 19(5):1080-1081. PubMed ID: 28467901
[No Abstract] [Full Text] [Related]
53. PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress.
Castelli V; Catanesi M; Alfonsetti M; Laezza C; Lombardi F; Cinque B; Cifone MG; Ippoliti R; Benedetti E; Cimini A; d'Angelo M
Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33525605
[TBL] [Abstract][Full Text] [Related]
54. Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment.
Fidoamore A; Cristiano L; Laezza C; Galzio R; Benedetti E; Cinque B; Antonosante A; d'Angelo M; Castelli V; Cifone MG; Ippoliti R; Giordano A; Cimini A
Oncotarget; 2017 Dec; 8(65):108430-108450. PubMed ID: 29312541
[TBL] [Abstract][Full Text] [Related]
55. Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes.
Kushwaha R; Mishra J; Tripathi S; Khare P; Bandyopadhyay S
Mol Neurobiol; 2018 Mar; 55(3):2125-2149. PubMed ID: 28283887
[TBL] [Abstract][Full Text] [Related]
56. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.
Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG
Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108
[TBL] [Abstract][Full Text] [Related]
57. Innovative Therapies against Human Glioblastoma Multiforme.
Cimini A; Ippoliti R
ISRN Oncol; 2011; 2011():787490. PubMed ID: 22091432
[TBL] [Abstract][Full Text] [Related]
58. PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.
Benedetti E; Galzio R; D'Angelo B; Cerù MP; Cimini A
PPAR Res; 2010; 2010():427401. PubMed ID: 20339586
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
